BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6413740)

  • 41. Low urinary excretion of heparan sulfate in three patients with Lowe's syndrome.
    Yokoi T; Uozaki T; Kasei M; Sato T; Taniguchi N
    Clin Chim Acta; 1981 Oct; 116(2):153-60. PubMed ID: 6457705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anomalous structure of urinary chondroitin sulfate from cancer patients. A potential new marker for diagnosis of neoplasias.
    Dietrich CP; Martins JR; Sampaio LO; Nader HB
    Lab Invest; 1993 Apr; 68(4):439-45. PubMed ID: 8479152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in connective tissue metabolism due to bone fractures in children aged 10--14 years. I. Urinary hydroxyproline and glycosaminoglycan excretion during fracture repair.
    Kustos G
    Acta Chir Acad Sci Hung; 1979; 20(1):69-78. PubMed ID: 554381
    [No Abstract]   [Full Text] [Related]  

  • 44. Increased urine heparan and chondroitin sulphate excretion in patients with osteopetrosis.
    Steiner RD; Whyte MP; Chang E; Hanks J; Mattes C; Senephansiri H; Gibson KM
    J Inherit Metab Dis; 2000 Feb; 23(1):88-90. PubMed ID: 10682314
    [No Abstract]   [Full Text] [Related]  

  • 45. Urinary glycosaminoglycan excretion in normal and stone-forming subjects: significant disturbance in recurrent stone formers.
    Nikkilä MT
    Urol Int; 1989; 44(3):157-9. PubMed ID: 2749930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urine glycosaminoglycans in congenital and acquired nephrotic syndrome.
    Jadresic LP; Filler G; Barratt TM
    Kidney Int; 1991 Aug; 40(2):280-4. PubMed ID: 1942776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A study of glycosaminoglycan excretion in normal and stone-forming subjects using a modified cetylpyridinium chloride technique.
    Samuell CT
    Clin Chim Acta; 1981 Nov; 117(1):63-73. PubMed ID: 7333013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age differences in the pattern of urinary glycosaminoglycan excretion in normal individuals.
    Taniguchi N
    Clin Chim Acta; 1972 Mar; 37():225-33. PubMed ID: 4259966
    [No Abstract]   [Full Text] [Related]  

  • 49. Glycosaminoglycan content in tissues and body fluids of rats treated with atherogenic diet.
    Drózdz M; Kucharz E; Głowacki A
    Acta Biol Med Ger; 1979; 38(10):1473-7. PubMed ID: 121507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A low-sulfated chondroitin sulfate in rat blood: an acidic glycosaminoglycan with a high metabolic rate.
    Hata RI; Nagai Y
    Biochim Biophys Acta; 1978 Oct; 543(2):149-55. PubMed ID: 728457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycosaminoglycans in urolithiasis.
    Nesse A; Garbossa G; Romero MC; Bogado CE; Zanchetta JR
    Nephron; 1992; 62(1):36-9. PubMed ID: 1436289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary glycosaminoglycan excretion in urolithiasis.
    Akçay T; Konukoğlu D; Dínçer Y
    Arch Dis Child; 1999 Mar; 80(3):271-2. PubMed ID: 10325710
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
    Zhang H; Wood T; Young SP; Millington DS
    Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Urinary glycosaminoglycans in peptic ulcer, chronic gastritis, and normal subjects].
    Rabinovich PD; Gerasimovich AI
    Vopr Med Khim; 1980; 26(4):545-8. PubMed ID: 6779420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urinary excretion of glycosaminoglycans in normal and stone forming subjects.
    Michelacci YM; Glashan RQ; Schor N
    Kidney Int; 1989 Dec; 36(6):1022-8. PubMed ID: 2601252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pattern of urinary acid mucopolysaccharide excretion in five patients with genetic mucopolysaccharidoses.
    Orii T; Minami R; Takase A; Nakao T
    Tohoku J Exp Med; 1973 May; 110(1):41-8. PubMed ID: 4269662
    [No Abstract]   [Full Text] [Related]  

  • 57. Prospective Evaluation of Chondroitin Sulfate, Heparan Sulfate and Hyaluronic Acid in Prostate Cancer.
    da Silva MNR; Mendes A; Martins JRM; Tobias-Machado M; Pinhal MADS
    Int Braz J Urol; 2018; 44(6):1139-1146. PubMed ID: 30516927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The application of high-performance liquid chromatography in enzymatic assays of chondroitin sulfate isomers in normal human urine.
    Lee GJ; Tieckelmann H
    J Chromatogr; 1981 Jan; 222(1):23-31. PubMed ID: 6783674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Isolation of urinary heparan sulfate and chondroitin sulfate and their inhibitory activity of calcium oxalate crystal growth].
    Iwata H; Terado T; Kin M; Nishio S; Matsumoto A; Takeuchi M
    Nihon Hinyokika Gakkai Zasshi; 1991 Mar; 82(3):405-11. PubMed ID: 1906557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enzymatic studies of urinary isomeric chondroitin sulfates from patients with mucopolysaccharidoses. The application of high performance liquid chromatography.
    Lee GJ; Evans JE; Tieckelmann H; Dulaney JT; Naylor EW
    Clin Chim Acta; 1980 May; 104(1):65-75. PubMed ID: 6771063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.